{"id":"https://openalex.org/W2991640940","doi":"https://doi.org/10.1200/jco.2019.37.31_suppl.106","title":"Understanding barriers to oral medication adherence in adults with acute myeloid leukemia (AML).","display_name":"Understanding barriers to oral medication adherence in adults with acute myeloid leukemia (AML).","publication_year":2019,"publication_date":"2019-11-01","ids":{"openalex":"https://openalex.org/W2991640940","doi":"https://doi.org/10.1200/jco.2019.37.31_suppl.106","mag":"2991640940"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.31_suppl.106","doi":"https://doi.org/10.1200/jco.2019.37.31_suppl.106","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.31_suppl.106","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009509049","display_name":"Ashley Leak Bryant","orcid":"https://orcid.org/0000-0003-1178-1781","observed_orcids":["https://orcid.org/0000-0003-1178-1781"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashley Leak Bryant","raw_affiliation_strings":["University of North Carolina, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027919691","display_name":"Ya\u2010Ning Chan","orcid":"https://orcid.org/0000-0002-7045-2892","observed_orcids":["https://orcid.org/0000-0002-7045-2892"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ya-Ning Chan","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059776166","display_name":"Jaime Richardson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaime Richardson","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031561153","display_name":"Matthew Charles Foster","orcid":"https://orcid.org/0000-0002-6652-3838","observed_orcids":["https://orcid.org/0000-0002-6652-3838"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Charles Foster","raw_affiliation_strings":["University of North Carolina School of Medicine, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina School of Medicine, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064514151","display_name":"Debra M Wujcik","orcid":"https://orcid.org/0000-0002-3831-2654","observed_orcids":["https://orcid.org/0000-0002-3831-2654"]},"institutions":[{"id":"https://openalex.org/I4405267601","display_name":"Carevive Systems, Inc. (United States)","ror":"https://ror.org/03g9d0v67","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267601"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debra Wujcik","raw_affiliation_strings":["Carevive, Inc., Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carevive, Inc., Nashville, TN;","institution_ids":["https://openalex.org/I4405267601"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"31_suppl","first_page":"106","last_page":"106"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/3604","display_name":"Emergency Medical Services"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9409999847412109},{"id":"https://openalex.org/keywords/barriers-to-adherence","display_name":"barriers to adherence","score":0.8240000009536743},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.7519999742507935},{"id":"https://openalex.org/keywords/pill-burden","display_name":"medication burden","score":0.5350000262260437},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7369999885559082},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.7960000038146973},{"id":"https://openalex.org/keywords/pillbox","display_name":"pillbox","score":0.5870000123977661},{"id":"https://openalex.org/keywords/medication-scheduling","display_name":"drug scheduling","score":0.5360000133514404},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.5120000243186951},{"id":"https://openalex.org/keywords/caregivers","display_name":"caregivers","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9124487638473511},{"id":"https://openalex.org/C81603835","wikidata":"https://www.wikidata.org/wiki/Q3457430","display_name":"Pill","level":2,"score":0.5953322052955627},{"id":"https://openalex.org/C56995899","wikidata":"https://www.wikidata.org/wiki/Q1126687","display_name":"Focus group","level":2,"score":0.506159245967865},{"id":"https://openalex.org/C3018553135","wikidata":"https://www.wikidata.org/wiki/Q67004728","display_name":"Medication adherence","level":2,"score":0.4466201066970825},{"id":"https://openalex.org/C74196892","wikidata":"https://www.wikidata.org/wiki/Q7781188","display_name":"Thematic analysis","level":3,"score":0.4370872974395752},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4235795736312866},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3284369111061096},{"id":"https://openalex.org/C190248442","wikidata":"https://www.wikidata.org/wiki/Q839486","display_name":"Qualitative research","level":2,"score":0.2989199161529541},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2656193971633911},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.20294812321662903},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.0},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.31_suppl.106","doi":"https://doi.org/10.1200/jco.2019.37.31_suppl.106","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.31_suppl.106","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3034675529","https://openalex.org/W2990044876","https://openalex.org/W2989279256","https://openalex.org/W4389219365","https://openalex.org/W2902531394","https://openalex.org/W4387888385","https://openalex.org/W2890043450","https://openalex.org/W2604764556","https://openalex.org/W6949818995","https://openalex.org/W2414663116"],"abstract_inverted_index":{"106":[0],"Background:":[1],"AML":[2,15,80,92,115,280],"is":[3,17],"a":[4,256],"disease":[5],"of":[6,22,40,52,180,202,208,240,270],"older":[7],"adults":[8],"(median":[9],"age":[10],"67":[11],"years).":[12],"Although":[13],"standard":[14],"treatment":[16,65],"intravenous":[18],"(IV)":[19],"chemotherapy,":[20],"availability":[21],"oral":[23,75,166,173,247,275],"anti-cancer":[24],"medications":[25,76,197],"has":[26],"increased":[27,49],",":[28],"providing":[29,218],"benefits":[30],"and":[31,48,63,81,93,130,148,169,178,186,200,204,213,230,244],"risks":[32],"to":[33,69,72,74,98,171,246,254,258,261,273],"patients.":[34],"Patients":[35,235],"prefer":[36],"their":[37,55,94,122],"convenience,":[38],"absence":[39],"IV":[41],"infusions,":[42],"potential":[43],"for":[44,84,121,132,217],"fewer":[45],"clinic":[46],"visits,":[47],"subjective":[50],"feeling":[51],"control":[53],"over":[54],"disease.":[56],"Poor":[57],"adherence":[58,73,162,167,190,219,277],"can":[59],"increase":[60],"toxicity":[61],"risk":[62],"compromise":[64],"effectiveness.":[66],"We":[67],"aim":[68],"identify":[70],"barriers":[71,243],"in":[77,100,152,232,278],"patients":[78,90,141,263],"with":[79,91,225,264],"proposed":[82],"solutions":[83,245],"improvements.":[85],"Methods:":[86],"Following":[87],"IRB":[88],"approval,":[89],"caregivers":[95,150],"were":[96,125,252],"recruited":[97],"participate":[99],"focus":[101],"groups.":[102],"An":[103,189],"experienced":[104],"moderator":[105],"conducted":[106],"the":[107,279],"groups":[108],"using":[109,135],"an":[110,165,237,271],"interview":[111],"guide":[112],"developed":[113],"by":[114],"experts.":[116],"Participants":[117],"received":[118],"gift":[119],"cards":[120],"participation.":[123],"Sessions":[124],"digitally":[126],"recorded,":[127],"transcribed":[128],"verbatim,":[129],"analyzed":[131],"thematic":[133],"content":[134],"Dedoose":[136],"qualitative":[137],"software.":[138],"Results:":[139],"11":[140],"(5":[142],"<65":[143],"years;":[144],"6":[145],">65":[146],"years)":[147],"4":[149],"participated":[151],"sessions":[153],"lasting":[154],"60-75":[155],"minutes.":[156],"Three":[157],"central":[158],"themes":[159],"emerged:":[160],"medication":[161,248,276],"challenges,":[163],"managing":[164],"plan,":[168],"strategies":[170],"improve":[172,274],"adherence.":[174,249],"Adherence":[175],"challenges:":[176],"number":[177],"size":[179],"pills,":[181],"different":[182],"directions,":[183],"cost,":[184],"availability,":[185],"side":[187],"effects.":[188],"plan":[191],"was":[192],"recommended:":[193],"written":[194],"schedules,":[195],"take":[196],"around":[198],"meals,":[199],"use":[201],"pillboxes":[203],"alarms.":[205],"Main":[206],"sources":[207],"information:":[209],"health":[210],"care":[211],"team":[212],"bottle":[214],"directions.":[215],"Recommendations":[216],"assistance":[220,224],"included":[221],"better":[222],"instructions,":[223],"scheduling,":[226],"making":[227],"pills":[228],"smaller,":[229],"consistency":[231],"packaging.":[233],"Conclusions:":[234],"are":[236],"important":[238],"source":[239],"insight":[241],"into":[242],"These":[250],"responses":[251],"used":[253],"develop":[255],"survey":[257],"be":[259],"administered":[260],"100":[262],"AML.":[265],"Results":[266],"will":[267],"inform":[268],"development":[269],"intervention":[272],"population.":[281]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-12-05T00:00:00"}